DBV Technologies S.A. (DBVT)
NASDAQ·Healthcare·Biotechnology
$10.81
+3.44%
Mkt Cap $283.47M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$46.33
Range $40.00 – $51.00
Implied Upside
+328.6%
Consensus $46.33 vs current $10.81
NASDAQ·Healthcare·Biotechnology
$10.81
+3.44%
Mkt Cap $283.47M
No recent rating data.
Price Target (7 analysts)
$46.33
Range $40.00 – $51.00
+328.6%
Consensus $46.33 vs current $10.81